Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 42,469 | 10,789 | 9,626 | 9,419 | 7,357 |
| Gross Profit | 42,469 | 10,789 | 9,626 | 9,419 | 7,357 |
| Operating Expenses | 22,670 | 21,672 | 20,719 | 19,360 | 18,889 |
| Operating Income | 19,799 | -10,883 | -11,093 | -9,941 | -11,532 |
| Other Income | 2,291 | 1,687 | 895 | 1,123 | 1,121 |
| Pre-tax Income | 22,090 | -9,196 | -10,198 | -8,818 | -10,411 |
| Income Tax | N/A | N/A | N/A | N/A | -76 |
| Net Income Continuous | 22,090 | -9,196 | -10,198 | -8,818 | -10,335 |
| Net Income | $22,090 | $-9,196 | $-10,198 | $-8,818 | $-10,335 |
| EPS Basic Total Ops | 2.67 | -0.72 | -1.33 | -1.17 | -1.54 |
| EPS Basic Continuous Ops | 2.69 | -0.72 | -1.33 | -1.17 | -1.55 |
| EPS Diluted Total Ops | 2.67 | -0.72 | -1.33 | -1.17 | -1.54 |
| EPS Diluted Continuous Ops | 2.69 | -0.72 | -1.33 | -1.17 | -1.55 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.72 | -1.33 | -1.17 | -1.57 |
| EBITDA(a) | $19,003 | $-11,482 | $-11,440 | $-10,416 | $-12,093 |